U2Bio Co., Ltd. (KOSDAQ:221800)
4,650.00
-160.00 (-3.33%)
At close: Feb 5, 2026
62.59% (1Y)
| Market Cap | 60.68B +53.6% |
| Revenue (ttm) | 25.59B -2.6% |
| Net Income | -2.99B |
| EPS | -265.81 |
| Shares Out | 13.54M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 71,918 |
| Average Volume | 1,538,252 |
| Open | 4,720.00 |
| Previous Close | 4,810.00 |
| Day's Range | 4,650.00 - 4,830.00 |
| 52-Week Range | 2,700.00 - 7,900.00 |
| Beta | -0.12 |
| RSI | 43.37 |
| Earnings Date | n/a |